==== Front World J Surg World J Surg World Journal of Surgery 0364-2313 1432-2323 Springer International Publishing Cham 37079104 6996 10.1007/s00268-023-06996-5 Original Scientific Report Early Postoperative Results after Thymectomy for Thymic Cancer: A Single-Institution Experience Petroncini Matteo 1Dr. Matteo Petrocini was born in Bologna, Italy, in 1994. He graduated cum laude from the University of Bologna in 2019. In 2021, he started his residency in General Thoracic Surgery at the University of Bologna. His main clinical interests are minimally invasive surgery and lung transplantation. He is a member of the Italian Society of Thoracic Surgery (SICT) and the European Association for Cardio-Thoracic Surgery (EACTS). His research has focused on the comparison of the outcomes of different minimally invasive techniques. Before starting his residency, he achieved piano graduation at Conservatorio G.B. Martini in Bologna, and he still loves to play the piano in his spare time. He can also prepare wonderful homemade tortellini. Solli Piergiorgio 1 Brandolini Jury 1 Lai Giulia 1 Antonacci Filippo 1 Garelli Elena 1 Kawamukai Kenji 1 Forti Parri Sergio Nicola 1 Bonfanti Barbara 1 Dolci Giampiero 1 http://orcid.org/0000-0002-6267-0099 Bertoglio Pietro pietro.bertoglio2@unibo.it 12 1 grid.6292.f 0000 0004 1757 1758 Division of Thoracic Surgery, IRCCS Azienda Ospedaliero Universitaria Di Bologna, Via Albertoni 15, 40138 Bologna, Italy 2 grid.6292.f 0000 0004 1757 1758 Alma Mater Studiorum, Università di Bologna, Bologna, Italy 20 4 2023 20 4 2023 2023 47 8 19781985 26 2 2023 © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Background Surgery for thymic cancers is considered the key of curative treatment. Preoperative patients’ characteristics and intraoperative features might influence postoperative outcome. We aim to verify short-term outcomes and possible risk factors for complications after thymectomy. Methods We retrospectively investigated patients undergoing surgery for thymoma or thymic carcinoma in the period between January 1, 2008, and December 31, 2021, in our department. Preoperative features, surgical technique (open, bilateral VATS, RATS), intraoperative characteristics and incidence of postoperative complications (PC) were analyzed. Results We included in the study 138 patients. Open surgery was performed in 76 patients (55.1%), in 36 VATS (26.1%) and in 26 RATS (36.1%). Resection of one or more adjacent organs due to neoplastic infiltration was required in 25 patients. PC appeared in 25 patients (52% Clavien–Dindo grade I, 12% grade IVa). Open surgery had a higher incidence of PC (p < 0.001), longer postoperative in-hospital stay (p = 0.045) and larger neoplasm (p = 0.006). PC were significant related to pulmonary resection (p = 0.006), phrenic nerve resection (p = 0.029), resection of more than one organ (p = 0.009) and open surgery (p = 0.001), but only extended surgery of more organs was confirmed as independent prognostic factor for PC (p = 0.0013). Patients with preoperative myasthenia symptoms have a trend toward stage IVa complications (p = 0.065). No differences were observed between outcomes of VATS and RATS. Conclusions Extended resections are related to a higher incidence of PC, while VATS and RATS guarantee a lower incidence of PC and shorter postoperative stay even in patients that require extended resections. Symptomatic myasthenia patients might have a higher risk toward more severe complications. Alma Mater Studiorum - Università di BolognaOpen access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement. issue-copyright-statement© Société Internationale de Chirurgie 2023 ==== Body pmcIntroduction Thymomas and thymic carcinomas are rare neoplasm arising from thymic epithelial cells, and although rare, they are the most frequent neoplasm of the anterior mediastinum [1, 2]. Their behavior is strictly dependent on histological features and a local infiltration of adjacent structures and organs is possible [3, 4]. Surgery is a curative treatment for thymic cancer and can be offered even in case of loco-regional metastatic diseases [2]. Recently, the technological innovation brought radical changes in the paradigms of thymic surgery: From the classical open surgery (via sternotomy, thoracotomy or clamshell incision), there was a shift toward a less invasive approach using video-assisted thoracic surgery (VATS) or robot-assisted thoracic surgery (RATS) [5, 6]. Although the superiority of the minimally invasive surgery (MIS) approach is still a matter of debate, some recent papers including two RCTs have highlighted potential advantages in terms of short-term outcomes for lung cancer patients treated with VATS compared to thoracotomy [7, 8]. The same applies to thymus surgery, where MIS has gradually become a well-established alternative approach in clinical practice, for both malignant and benign diseases, even though this approach has not been supported yet by prospective studies [2]. Nevertheless, locally aggressive disease might require extended resections of one or more surrounding organs (e.g., lung, chest wall, pericardium, phrenic nerve) increasing the difficulty of procedures that might require to be performed by open technique according to the extent of the disease and of the experience of the surgeon [4, 9]. The present study is focused on short-term surgical outcomes and associated risk factors, regardless of the technique. Data have been retrospectively collected from a single-center large institutional database across a 14-year period. Patients and methods This study was approved by the ethical committee of Bologna (protocol number 721/2022/Oss/AOUBo). Patients We retrospectively collected all consecutive patients who underwent surgery for thymic neoplasm (both thymoma and thymic carcinoma) at our institution from January 1, 2008, to December 31, 2021. All patients with incomplete perioperative information were excluded. All cases were restaged according to the eighth edition of TNM classification. PC were recorded according to the Clavien–Dindo score [10]; when a patient experienced more than one complication of different grade, he was assigned with the highest grade. Thirty- and 90-day mortality and hospital readmission in the first 90 days after surgery were also recorded. Surgical techniques Surgical technique was decided according to the availability of MIS technologies and according to surgeon preference. Surgery encompassed resection of the whole thymus en-bloc with surrounding fat tissue between phrenic nerves. Open approaches included sternotomy, antero-lateral thoracotomy, cervicotomy or sternal splits, and they were performed in a standard manner. An open approach was mostly used in the first period 2008–2014 or even recently in case of large lesions with associated infiltration of surrounding structures deemed not suitable for a radical treatment with MIS surgery. VATS technique was represented by either a unilateral or bilateral approach. Unilateral approach consisted in a standard three-portal technique with incision made around the breast; the side of the intervention was left to surgeons’ choice. Our standard bilateral approach was already described elsewhere [11]. Robotic procedures were performed using the Da Vinci© platform, Xi version. Thymectomy was carried out according to standard techniques already described by other authors [5]. Although the side of intervention was based on surgeon’s preference according to anatomic features of the tumor, a left-side approach was generally preferred. Statistical analysis Data were analyzed using the software SPSS version 26.0 for IOS (Chicago, USA). Continuous variables were expressed in terms of mean with standard deviation (SD) or median with range, while categorical variables were expressed in terms of frequency. Two-tailed Pearson’s Chi-square test was used for intergroup comparison of categorical variables, while the Student’s T test and ANOVA test were used for continuous variables. Multivariable analysis was performed with logistic binary regression only with variables which had at least a p value ≤ 0.05 at the univariate analysis. Variables considered for univariate analysis were those clinically relevant and that better define postoperative outcomes: age, sex, tumor dimension, extended resection, type of extended resection, preoperative myasthenia and preoperative presence of symptoms due to myasthenia. The hazard ratio (HR) and 95% confidence intervals (CI) were reported for covariates. Results In the study period, 138 patients underwent thymectomy for thymoma or thymic carcinoma in our institution. Table 1 reports the main features of the population. Briefly, the majority of patients were female (73, 52.9%) and the mean age was 59.7 years (range 19–86). Respiratory comorbidities (mainly COPD) were present in 19 (13.8%) patients, while 32 had cardiovascular comorbidities; myasthenia was present in 40 patients (29.0%).Table 1 Preoperative, intraoperative and postoperative features of patients of the entire cohort and comparison between those treated with open and minimally invasive surgery Whole cohort Open Minimally invasive p Sex (n, %) Male 65 (47.1) 30 (39.5) 35 (56.5) 0.035 Age (mean, range) 59.7 (19–86) 60.7 (25–86) 58.5 (19–85) 0.402 Respiratory comorbidities (n, %) Yes 19 (13.8) 12 (15.8) 7 (11.3) 0.347 Cardiac comorbidities (n, %) Yes 32 (23.2) 15 (19.7) 17 (27.4) 0.152 Previous cancers (n, %) Yes 31 (22.5) 17 (22.4) 14 (22.6) 0.506 Pre-surgical myasthenia (n, %) Yes 40 (29.0) 21 (27.6) 19 (30.6) 0.348 Symptoms myastenia (n, %) Yes 22 (15.9) 15 (19.7) 7 (11.3) 0.118 ASA (n, %) 1 2 3 4 30 (21.7) 61 (44.2) 28 (20.3) 19 (13.8) 14 (18.3) 35 (46.1) 16 (21.1) 11 (14.5) 16 (25.8) 26 (41.9) 12 (19.4) 8 (12.9) 0.263 SUVmax (mean, ± SD) 8.5 (11.6) 4.9 (1.2) 13.2 (± 17.1) 0.106 Mean tumor diameter (mm, ± SD) 49.3 (± 30.0) 55.5 (± 34.2) 41.2 (± 19.6) 0.008 TNM stage (n, %) I II IIIA/B IV 109 (79.0) 6 (4.3) 8 (5.8) 15 (10.9) 51 (67.1) 6 (7.9) 6 (7.9) 13 (17.1) 58 (93.6) 0 (0.0) 2 (3.2) 2 (3.2) 0.003 Masaoka stage (n, %) I IIA/B III IV 40 (29.0) 84 (60.9) 9 (6.5) 5 (3.6) 21 (27.6) 44 (57.9) 7 (9.2) 4 (5.3) 19 (30.6) 40 (64.5) 2 (3.2) 1 (1.6) 0.471 Histology (WHO classification) A AB B1/2/3 Carcinoma 32 (23.2) 42 (30.4) 55 (39.9) 9 (6.5) 14 (18.4) 21 (27.6) 36 (47.4) 5 (6.6) 18 (29.0) 21 (33.9) 19 (30.6) 4 (6.5) 0.213 Surgical access (n, %) Open VATS RATS 76 (55.1) 36 (26.1) 26 (18.8) NA NA NA Extended resections (n, %) Yes 25 (18.1) 22 (28.9) 3 (4.8)  < 0.001 Surgical time in minutes (mean, ± SD) 139 (± 58) 137.2 (± 53.5) 141.4 (± 62.7) 0.674 Postoperative hospital stay in days (mean, ± SD) 6.3 (± 5.1) 7.1 (± 5.8) 5.2 (± 3.7) 0.045 Postoperative complications (n, %) Yes 25 (18.1) 21 (27.6) 4 (6.5) 0.001 Clavien–Dindo complications (n, %) I II III IVa 13 (52.0) 5 (20.0) 4 (16.0) 3 (12.0) 12 (15.8) 3 (3.9) 4 (5.3) 2 (2.6) 1 (1.6) 2 (3.2) 0 (0.0) 1 (1.6) 0.425 SUVmax maximal standard uptake value; VATS video-assisted thoracic surgery; RATS robot-assisted thoracic surgery Open technique was used in 76 patients (55.1%), while the remaining were treated with MIS techniques: 36 VATS (15 bilateral approach, 14 right approach and 7 left approach) and 26 RATS. The mean operative time was 139.1 min (± 57.7). No significant difference was seen between patients treated with open or MIS (p = 0.674). Conversely, the diameter of thymomas treated with VATS or RATS was significantly smaller compared to those treated with open surgery (p = 0.006). Thymic carcinoma was present in 6 patients, while among thymomas B type was the most common according to WHO classification. As reported in Table 1, most of patients were in stage I according to eighth TNM staging system and to Masaoka–Koga classification. There was no difference between open and VATS regarding WHO classification (p = 0.213) and Masaoka–Koga (p = 0.471), while we found a different distribution in TNM staging (p = 0.003). In 25 patients, a resection of adjacent organs was required for loco-regional infiltration: 5 patients required lung resection, 3 pericardial resection, 3 phrenic nerve resection, 1 vascular resection and 12 resection of more than one structure or organ. Among patients who underwent a phrenic nerve resection, at preoperative chest X-ray, 2 had a clear preoperative phrenic palsy, while in the remaining cases no preoperative palsy was detectable. Extended resections were significantly more frequent in open procedures compared to those carried either by VATS or RATS (p < 0.001) and in patients with higher TNM stage (p < 0.001) and Masaoka–Koga (p < 0.001). Estimation of intraoperative blood loss and evaluation of postoperative pain were outside the aims of the present study; moreover, due the retrospective setting of the study, we found a high rate of missing values that did not allow us to consider these data. All patients affected by myasthenia were admitted in the ICU for the first postoperative night for monitoring; moreover, 4 patients with cardiac comorbidities were admitted in the ICU after surgery for the same reason. All patients were discharged on the next days to the ordinary ward. The mean postoperative stay was 6.3 days (± 5.1), and we noticed a significant shorter course for patients treated with MIS (p = 0.045). Interestingly, no case of 30- or 90-day mortality was recorded. Only one patient was readmitted on postoperative day 36 due to medical reason (intestinal sub-occlusion and urinary tract infection), and none of the cases was readmitted for surgical post-discharge complications. Postoperative complications During the postoperative course, 25 patients experienced PC (18.1%) and, among them, 2 (1.4%) cases needed a redo surgery. Table 2 reports the details of each complication and the corresponding Clavien-Dindo classification. PC were more common in patients operated with an open technique (p = 0.001), but no difference was recorded in the rate of redo surgery (p = 0.164). The majority of complications (13, 52.0%) had a Clavien–Dindo grade I, while grade IVa was observed in 3 cases (12.0%). In 9 patients, more than one complication was reported.Table 2 Description of all postoperative complications occurred and their classification according to Clavien–Dindo classification Complication Clavien–Dindo classification Number of patients Pneumonia I 2 Dyspnea I 2 Pneumothorax not requiring chest drain I 1 Hypokalemia and hypocalcemia I 1 Fever > 38 °C I 2 Hypertension/tachycardia I 4 Vocal cord palsy I 3 Hemi-diaphragmatic palsy not requiring surgery I 1 Pleural effusion I 3 Left arm edema I 1 Pericarditis II 2 Chylothorax II 1 Anemia requiring blood transfusions II 4 Myasthenic crisis (not requiring intubation) II 2 Pneumothorax requiring chest drain IIIa 1 Atrial fibrillation IIIa 2 Hemothorax IIIb 2 Respiratory failure requiring intubation IVa 3 With regard to the incidence of PC, it was significantly higher in patients who underwent an extended surgery (p < 0.001): In particular, we notice a higher rate in those who underwent lung resection (p = 0.006), phrenic nerve resection (p = 0.029) or resection of more than one organ (p = 0.009); on the other hand, there was no significant correlation with pericardial or vascular resection (p = 0.459 and p = 0.816, respectively). Moreover, no correlation between surgical time and PC was noticed, even if there was trend toward a longer surgical duration (p = 0.069). Concurrently, preoperative features such as myasthenia (p = 0.256), myasthenia symptoms (p = 0.310), the presence of respiratory comorbidities (p = 0.526), cardiac comorbidities (p = 0.538) or both cardiac and respiratory comorbidities (p = 0.653) were not significantly related to PC, and neither were postoperative features such as TNM stage (p = 0.200), Masaoka–Koga stage (p = 0.192) and WHO histological classification (p = 0.176). On the other hand, complications were related to a significant longer postoperative length of stay (p < 0.001); interestingly, in this subgroup we did not observe differences in the length of postoperative course between those treated with open and MIS (p = 0.426). Multivariable analysis (Table 3) confirmed that only extended resection to multiple organs (p = 0.013) was associated with a higher incidence of PC, even though open surgery (p = 0.057) and phrenic nerve resection (p = 0.076) were closed to significance threshold.Table 3 Multivariable analysis of risk factors related to postoperative complications Variable HR CI 95% p Open surgery 3.215 0.967–10.687 0.057 Pulmonary resection 7.568 0.001–15.093 0.999 Phrenic nerve resection 9.508 0.787–114.831 0.076 Multiorgan resection 5.199 1.409–19.190 0.013 HR hazard ratio; CI confidence interval Bold values are statistically significant When we looked at different grades of complications according to the Clavien–Dindo classification, we could not find any significant correlation with preoperative features of patients such as respiratory (p = 0.585) or cardiologic (p = 0.976) comorbidities, previous cancers (p = 0.055) or the presence of myasthenia (p = 0.659). Patients with preoperative symptomatic myasthenia and those who had an extended resection of multiple organs showed a trend toward a higher incidence of Clavien–Dindo IVa complications (p = 0.060 and p = 0.065, respectively) even though non-significant. Lastly, length of postoperative course reflected the grade of complication (p = 0.010). VATS/RATS comparison We analyzed outcomes of 62 patients treated with MIS. Twenty-five patients (40.3%) were treated by RATS and 37 (59.7%) by VATS. No case of conversion to open surgery occurred in the study period. In this subgroup of patients, PC rate was 6.5% (4 patients) and they were not related to the extended resection (p = 0.816). Comparing VATS and RATS, we did not find any significant differences in terms of tumor diameter (p = 0.172), incidence of complications (0.533), grade of PC (p = 0.135) and rate of extended resections (p = 0.646). Surgical time (p = 0.515) and postoperative course (p = 0.336) were not significantly different between VATS and RATS. Comment Surgery for thymoma and thymic carcinoma has remained the main treatment throughout the decades. Sternotomy and open techniques have been gradually replaced by MIS which is nowadays commonly used, especially for early-stage and non-infiltrating thymomas [12]. Feasibility and safety of MIS have been extensively assessed by multiple retrospective reports and meta-analysis [5, 13–18]. Our results confirm some of the expected benefits of the MIS compared to open techniques (regardless of sternotomy or thoracotomy or combined approach): reduced morbidity and reduced length of stay. Conversely, the duration of surgery was similar, regardless of the chosen technique and in line with reports from the literature. In fact, length of surgery is inconsistently reported throughout the literature and MIS does not always guarantee faster surgical operations. Marulli and colleagues [5] comparing transsternal and robotic thymectomy found a significantly longer surgical time for patients treated with the latter technique, that become non-significant after a propensity score match; similar results were more recently reported by Hurd [19] in a cohort of patients affected by thymic carcinomas. On the other hand, Casiraghi [14] found a significant longer surgical time in open procedures compared to robotic ones. In the case of locally infiltrating lesions, the radical resection is still feasible in many cases but requires en-bloc excision of surrounding organs (lung, pericardium, phrenic nerve, vessels) [3, 20, 21]. Several studies reported outcomes of extended resections, but with an overall focus on long-term outcomes, with only few concentrated on early postoperative morbidity. In the present series, extended resections were associated with a significant higher incidence of immediate complications and were more often approached with an open technique than MIS. Also according to the literature, the role for MIS in the case of extended surgery for thymic neoplasms is still controversial and remains mainly correlated with anatomical features, abilities of surgeon and multidisciplinary attitude [9]. Soder and co-workers [22] retrospectively analyzed a monocentric 20-year experience in thymic surgery comparing open and robotic approach: They find a significant reduction in PC in the robotic group (6.8% versus 21.1%) despite a significant greater proportion of extended resections in the robotic group after a propensity score match. Conversely, in a small retrospective study, Chen [23] compared VATS and open surgery in the treatment of Masaoka stage III thymomas and they found that phrenic nerve and vena cava resection was more likely to be performed by open surgery rather than VATS. Nonetheless, in the vast majority of reported experiences, complex extended resections are performed by open sternotomy, thoracotomy or clamshell incision [3, 9, 21, 24, 25]. Concurrently, Kang [26] reported outcome of 59 patients with stage III thymic cancers which received open extended resection; he reported 5 patients with PC and he highlighted that patients that needed resection of more than one organ had a significant worse survival compared to those who had resection of a single organ. In our study, multiple organs involvement/resection had a significant longer surgical time and in-hospital course and it was the sole independent risk factor for PC. In our experience, the overall PC rate was 18.1%, with most of the complications recorded in the context of extended surgery. Almost half of them were minor morbidities (stage I according to Clavien–Dindo) and only 3 (12%) were major (stage IVa). In the subgroup of MIS complication rate was significantly decreased (6.5%) consistent with the report from Soder [22]. Notably, we did not observe any significant correlation between patients’ preoperative features and the severity of the complications. Although non-significant, we recorded a mild trend of stage IVa complications in patients with preoperative symptomatic myasthenia. In keeping with these observations, Kumar [27] found a significant higher incidence of PC in myasthenia patients compared to non-myasthenic in a series of thymoma operated on via robotic technique. Recently, Wu [28] compared results of robotic and VATS thymectomies, not identifying significant differences in terms of overall duration of the surgical procedure. O’Sullivan and co-workers [6] found overall similar outcomes between RATS and VATS, while a more recent contribute [29] highlighted shorter length of stay and reduced complication rate in the RATS subgroup. Data of our experience also include the initial development of the robotic program and therefore the learning curve period. We can speculate that any difference in surgical times and in postoperative in-hospital stay could be also affected from our growing experience making the subgroups not homogenous and underestimating one of the variables analyzed. The role of the learning curve on operative time has been also reported also by other authors [30, 31]. Moreover, this might be entitled by the gradual introduction of an ERAS approach in our institution. Our data do not allow to precisely and undoubtedly asses which technique offers the best postoperative results in the treatment of thymus cancers, especially for complex cases. Based on our data and our experience, we can speculate that robotic technique might have the widest potential to allow to safely perform complex extended resection with good postoperative outcomes. Nevertheless, it is of paramount importance to evaluate each case singularly based on surgeon’s personal skill and experience, patient’s anatomical features and available technologies. Our study presents some limitations. Firstly, the retrospective setting might have impaired the data collection and their quality. Secondly, the observation covers a long-time frame (14 years), where different standards of postoperative care were applied. It is worthwhile to mention the introduction of the concept of ERAS late in the 2010’s that has been applied especially to both MIS techniques and oppositely was not routine practice in the early phases when most of the patients were receiving a standard open approach. Third, the learning curves phase of each new technique, as discussed, might potentially have introduced additional bias and influenced the results. Eventually, the number of patients of our series of case and the single-center nature of the analysis offers additional limitations. On the other hand, to the best of our knowledge, our study is the first to report a comprehensive report from a single high-volume institutional database focusing on and comparing short-term results of different surgical approaches for thymic cancers. Conclusions In conclusion, we found that thymic surgery extended to more than one surrounding organ is a risk factor for PC. We also confirmed that MIS techniques, both VATS and RATS, are related to a lower incidence of PC and shorter postoperative length of stay even in patients that require extended resections. Our data did not show any preoperative features that might foresee the grade of PC, but we observe a possible tendency for more severe complications in patients with symptomatic myasthenia. Prospective and large studies are needed to confirm our findings. Funding Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. Declarations Conflict of interest The authors declare that they have no conflict of interest. Ethical approval This study was approved by the IRB of Bologna (protocol number 721/2022/Oss/AOUBo). Informed consent Informed consent was obtained from all individual participants included in the study. Consent for publication This study was presented at the 36th EACTS meeting (Milan, Italy, October 5–8, 2022). Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. ==== Refs References 1. Scorsetti M Leo F Trama A Thymoma and thymic carcinomas Crit Rev Oncol Hematol 2016 99 332 350 10.1016/j.critrevonc.2016.01.012 26818050 2. Falkson CB Vella ET Ellis PM Surgical, radiation, and systemic treatments of patients with thymic epithelial tumours: a clinical practice guideline J Thorac Oncol 2022 25 299 312 3. Hamanaka K Koyama T Matsuoka S Analysis of surgical treatment of Masaoka stage III–IV thymic epithelial tumors Gen Thorac Cardiovasc Surg 2018 66 12 731 735 10.1007/s11748-018-0996-9 30132223 4. Aprile V Bertoglio P Korasidis S Nerve-sparing surgery in advanced stage thymomas Ann Thorac Surg 2019 107 3 878 884 10.1016/j.athoracsur.2018.08.071 30336118 5. Marulli G Comacchio GM Schiavon M Comparing robotic and trans-sternal thymectomy for early-stage thymoma: a propensity score-matching study Eur J Cardiothorac Surg 2018 54 3 579 584 10.1093/ejcts/ezy075 29547970 6. O'Sullivan KE Kreaden US Hebert AE A systematic review of robotic versus open and video assisted thoracoscopic surgery (VATS) approaches for thymectomy Ann Cardiothorac Surg 2019 8 2 174 193 10.21037/acs.2019.02.04 31032201 7. Bendixen M Jørgensen OD Kronborg C Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial Lancet Oncol 2016 17 6 836 844 10.1016/S1470-2045(16)00173-X 27160473 8. Lim E Batchelor T Shackcloth M Study protocol for VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a UK multicentre randomised controlled trial with an internal pilot (the VIOLET study) BMJ Open 2019 9 10 e029507 10.1136/bmjopen-2019-029507 31615795 9. Tosi D Damarco F Franzi S Outcomes of extended surgical resections for locally advanced thymic malignancies: a narrative review Gland Surg 2022 11 3 611 621 10.21037/gs-21-642 35402207 10. Dindo D Demartines N Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 2004 240 2 205 213 10.1097/01.sla.0000133083.54934.ae 15273542 11. Brandolini J Video-assisted thoracoscopic thymectomy: bilateral approach Mini Inv Surg 2020 4 45 10.20517/2574-1225.2020.27 12. Kamel MK Villena-Vargas J Rahouma M National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches† Eur J Cardiothorac Surg 2019 56 4 762 769 10.1093/ejcts/ezz111 31321412 13. Yang Y Dong J Huang Y Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: a meta-analysis Eur J Surg Oncol 2016 42 11 1720 1728 10.1016/j.ejso.2016.03.029 27139936 14. Casiraghi M Galetta D Borri A Tessitore A Romano R Brambilla D Robotic-assisted thymectomy for early-stage thymoma: a propensity-score matched analysis J Robot Surg 2018 12 4 719 724 10.1007/s11701-018-0816-3 29705833 15. Friedant AJ Handorf EA Su S Scott WJ Minimally invasive versus open thymectomy for thymic malignancies: systematic review and meta-analysis J Thorac Oncol 2016 11 1 30 8 10.1016/j.jtho.2015.08.004 26762737 16. Şehitogullari A Nasır A Anbar R Erdem K Bilgin C Comparison of perioperative outcomes of videothoracoscopy and robotic surgical techniques in thymoma Asian J Surg 2020 43 1 244 250 10.1016/j.asjsur.2019.04.005 31047770 17. Yang CJ Hurd J Shah SA A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma J Thorac Cardiovasc Surg 2020 160 2 555 567.e15 10.1016/j.jtcvs.2019.11.114 32245668 18. Hwang SK Lee GD Kang CH Long-term outcome of minimally invasive thymectomy versus open thymectomy for locally advanced cases Eur J Cardiothorac Surg 2022 62 3 ezac238 10.1093/ejcts/ezac238 35445251 19. Hurd J Haridas C Potter A A national analysis of open versus minimally invasive thymectomy for stage I–III thymic carcinoma Eur J Cardiothorac Surg 2022 62 3 ezac159 10.1093/ejcts/ezac159 35259241 20. Modh A Rimner A Allen PK Greenfield B Marom EM Rice D Treatment modalities and outcomes in patients with advanced invasive thymoma or thymic carcinoma: a retrospective multicenter study Am J Clin Oncol 2016 39 2 120 125 10.1097/COC.0000000000000024 24390276 21. Yamada Y Yoshino I Nakajima J Surgical outcomes of patients with stage III thymoma in the Japanese nationwide database Ann Thorac Surg 2015 100 3 961 967 10.1016/j.athoracsur.2015.04.059 26163354 22. Soder SA Pollock C Ferraro P Post-operative outcomes associated with open versus robotic thymectomy: a propensity matched analysis Semin Thorac Cardiovasc Surg 2021 35 189 199 10.1053/j.semtcvs.2021.11.011 34838953 23. Chen L Xie C Lin Q Video-assisted thoracoscopy versus open approach in patients with Masaoka stage III thymic epithelial tumors Transl Cancer Res 2019 8 3 962 967 10.21037/tcr.2019.06.02 35116835 24. Wright CD Extended resections for thymic malignancies J Thorac Oncol 2010 5 10 Suppl 4 S344 S347 10.1097/JTO.0b013e3181f20eb3 20859130 25. Aprile V Korasidis S Bacchin D Petralli G Petrini I Ricciardi R Ambrogi MC Lucchi M Thymectomy in myasthenic patients with thymoma: killing two birds with one stone Ann Thorac Surg 2021 112 6 1782 1789 10.1016/j.athoracsur.2020.12.010 33358889 26. Kang MW Lee ES Jo J Stage III thymic epithelial neoplasms are not homogeneous with regard to clinical, pathological, and prognostic features J Thorac Oncol 2009 4 12 1561 1567 10.1097/JTO.0b013e3181b9cd7f 19745769 27. Kumar A Asaf BB Pulle MV Myasthenia is a poor prognostic factor for perioperative outcomes after robotic thymectomy for thymoma Eur J Cardiothorac Surg 2021 59 4 807 813 10.1093/ejcts/ezaa406 33279991 28. Meacci E Nachira D Congedo MT Learning curve of robot-assisted thymectomy: single surgeon's 7-years experience Front Surg 2022 9 860899 10.3389/fsurg.2022.860899 36034391 29. Wu WJ Zhang FY Xiao Q Does robotic-assisted thymectomy have advantages over video-assisted thymectomy in short-term outcomes? a systematic view and meta-analysis Interact Cardiovasc Thorac Surg 2021 33 3 385 394 10.1093/icvts/ivab109 33997899 30. Kamel MK Rahouma M Stiles BM Nasar A Altorki NK Port JL Robotic thymectomy: learning curve and associated perioperative outcomes J Laparoendosc Adv Surg Tech A 2017 27 7 685 690 10.1089/lap.2016.0553 28121481 31. Shen C Li J Li J Che G Robot-assisted thoracic surgery versus video-assisted thoracic surgery for treatment of patients with thymoma: a systematic review and meta-analysis Thorac Cancer 2022 13 2 151 161 10.1111/1759-7714.14234 34806328